Cargando…
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535619/ https://www.ncbi.nlm.nih.gov/pubmed/36129137 http://dx.doi.org/10.3892/or.2022.8411 |
| _version_ | 1784802812268380160 |
|---|---|
| author | Ye, Song Zhao, Xin-Yi Hu, Xiao-Ge Li, Tang Xu, Qiu-Ran Yang, Huan-Ming Huang, Dong-Sheng Yang, Liu |
| author_facet | Ye, Song Zhao, Xin-Yi Hu, Xiao-Ge Li, Tang Xu, Qiu-Ran Yang, Huan-Ming Huang, Dong-Sheng Yang, Liu |
| author_sort | Ye, Song |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9535619 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | D.A. Spandidos |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95356192022-10-21 TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma Ye, Song Zhao, Xin-Yi Hu, Xiao-Ge Li, Tang Xu, Qiu-Ran Yang, Huan-Ming Huang, Dong-Sheng Yang, Liu Oncol Rep Corrigendum D.A. Spandidos 2022-09-19 /pmc/articles/PMC9535619/ /pubmed/36129137 http://dx.doi.org/10.3892/or.2022.8411 Text en Copyright: © Ye et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
| spellingShingle | Corrigendum Ye, Song Zhao, Xin-Yi Hu, Xiao-Ge Li, Tang Xu, Qiu-Ran Yang, Huan-Ming Huang, Dong-Sheng Yang, Liu TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma |
| title | TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma |
| title_full | TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma |
| title_fullStr | TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma |
| title_full_unstemmed | TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma |
| title_short | TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma |
| title_sort | tp53 and ret may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535619/ https://www.ncbi.nlm.nih.gov/pubmed/36129137 http://dx.doi.org/10.3892/or.2022.8411 |
| work_keys_str_mv | AT yesong tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma AT zhaoxinyi tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma AT huxiaoge tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma AT litang tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma AT xuqiuran tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma AT yanghuanming tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma AT huangdongsheng tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma AT yangliu tp53andretmayserveasbiomarkersofprognosticevaluationandtargetedtherapyinhepatocellularcarcinoma |